![]() |
市場調查報告書
商品編碼
1787982
全球葉酸市場預測(至 2032 年):按等級、產地、形式、通路、用途和地區分類Folic Acid Market Forecasts to 2032 - Global Analysis By Grade, Source, Form, Distribution Channel, Application, and By Geography |
根據 Stratistics MRC 的數據,全球葉酸市場規模預計在 2025 年達到 11.5 億美元,到 2032 年將達到 15.7 億美元,預測期內的複合年成長率為 4.6%。
葉酸是維生素B9的合成形式,用於膳食補充劑和食品強化。它在DNA合成、細胞分裂和紅血球生成中發揮重要作用。通常建議孕婦補充葉酸,以幫助預防發育中胎兒的神經管缺陷。葉酸是一種水溶性維生素,對整體代謝功能至關重要,並被廣泛納入減少分娩相關併發症的公共衛生策略中。
根據美國疾病管制與預防美國(CDC)的數據,受孕前每天服用400微克葉酸,可使神經管缺陷的風險降低約80%。
增加膳食補充劑的消費
膳食補充劑消費的成長持續推動葉酸市場的發展。隨著消費者高度重視預防性醫療保健和主動健康,人們越來越傾向於選擇含葉酸的強化食品、膳食補充劑和功能性產品。此外,持續的公共衛生宣傳活動也提高了人們對葉酸在預防神經管缺陷和支持整體健康方面作用的認知,尤其是在孕婦和存在葉酸缺乏風險的人群中。注重健康的生活方式與食品科學技術創新的融合預計將進一步刺激市場需求。
開發中地區公眾意識有限
儘管全球都在努力,但發展中地區對葉酸健康益處的認知不足仍然是限制其發展的一大因素。許多地區對葉酸缺乏的後果(例如貧血和發育遲緩)仍有認知差距,導致強化葉酸產品和補充劑的攝取量較低。此外,政府主導的營養計劃和醫療基礎設施的差異也對普及教育和有效市場滲透構成挑戰。新興經濟體持續缺乏葉酸認知,這繼續限制葉酸市場成長潛力的充分發揮。
拓展至機能性食品及飲料
隨著製造商不斷創新,將葉酸添加到零嘴零食、飲料、穀物和乳製品中,消費者將能夠無縫補充每日攝取量。此外,協調一致的政府措施和食品強化法規為市場參與企業創造了充足的空間,使其能夠豐富產品組合併開發新產品,以滿足不斷變化的消費者偏好。人們越來越注重更健康的飲食習慣,注重便利性和營養強化,預計將進一步推動市場發展。
替代維生素和營養素
隨著消費者日益青睞種類繁多的綜合維他命和替代性微量營養素補充劑,葉酸在宣傳活動和產品配方方面都面臨著競爭。消費者越來越關注整體營養,而非單一營養素,這可能會分散人們對葉酸特定產品的注意力和支出。此外,針對類似健康狀況的替代成分有效性的研究也日漸深入,這可能會威脅葉酸在某些消費群體中的主導地位。
新冠疫情提高了人們對預防保健和免疫系統支持的認知,對葉酸市場產生了積極影響。隨著消費者在危機期間更加重視健康,對含葉酸補充劑的需求顯著增加。此外,人們越來越意識到微量營養素在對抗疾病和支持整體健康方面的重要性,這也導致了強化葉酸產品的消費增加。這種健康意識的增強可能會增強市場的持續成長,並在疫情結束後產生持久的影響。
預計醫藥級細分市場在預測期內將佔最大佔有率
預計在預測期內,藥用級葉酸將佔據最大的市場佔有率,這得益於處方藥和孕產婦補充劑中藥用級葉酸的廣泛應用,而這些產品對產品的純度、效力和合規性至關重要。此細分市場受益於營養缺乏症盛行率的上升、育齡婦女補充劑攝取量的增加以及醫療保健專業人士的推薦。此外,市場佔有率人口的不斷成長使人們面臨更高的營養缺乏相關併發症的風險,這也推動了對藥用級葉酸解決方案的強勁需求。
預計在預測期內,線上部分將以最高的複合年成長率成長。
預計線上市場將在預測期內實現最高成長率,這主要得益於電商平台的便利性和可近性,使消費者和小買家能夠輕鬆購買葉酸補充劑。疫情加速了數位健康通路的普及,消費者對非接觸式購物的偏好日益成長,這進一步刺激了線上銷售。此外,線上平台產品日益多樣化和價格競爭力的提升也促進了強勁成長。
預計北美將在預測期內佔據最大的市場佔有率,這得益於其成熟的醫療基礎設施、對孕產婦營養重要性的高度認知以及完善的政府強化法規。強化食品和膳食補充劑的普及,以及主要製藥和膳食補充劑公司在研發方面的大量投入,進一步鞏固了北美的主導。此外,確保全民葉酸攝取的監管標準以及龐大的老化人口規模,將繼續支撐該地區龐大的市場需求。
預計亞太地區將在預測期內實現最高的複合年成長率。該地區市場的快速擴張得益於可支配收入的提高、健康意識的增強以及政府為消除營養不良而採取的積極舉措。中國和印度等國家正透過廣泛的公共衛生計劃和針對婦女和兒童的免費補充劑供應計劃來推動這一成長。此外,不斷壯大的中階和持續加強的醫療基礎設施預計將維持該地區葉酸需求的高速成長軌跡。
According to Stratistics MRC, the Global Folic Acid Market is accounted for $1.15 billion in 2025 and is expected to reach $1.57 billion by 2032 growing at a CAGR of 4.6% during the forecast period. Folic acid is a synthetic form of vitamin B9 used in dietary supplements and food fortification. It plays a vital role in DNA synthesis, cell division, and red blood cell production. Commonly recommended for pregnant women, it helps prevent neural tube defects in developing fetuses. As a water-soluble vitamin, folic acid is crucial for overall metabolic function and is widely included in public health strategies to reduce birth-related complications.
According and data from the U.S. Centers for Disease Control and Prevention (CDC), daily intake of 400 micrograms of folic acid before conception can reduce the risk of neural tube defects by approximately 80%.
Increasing nutraceutical consumption
Rising consumption of nutraceuticals continues to propel the folic acid market. As consumers place higher value on preventative healthcare and proactive wellness, there is a notable shift toward fortified foods, dietary supplements, and functional products containing folic acid. Moreover, sustained public health campaigns have raised awareness about the role of folic acid in preventing neural tube defects and supporting overall health, particularly for pregnant women and populations at risk for deficiencies. The convergence of health-conscious lifestyles and innovation in food science is expected to further accelerate market demand.
Limited public awareness in developing regions
Despite global efforts, limited awareness about the health benefits of folic acid remains a prominent constraint in developing regions. In many areas, knowledge gaps persist regarding the consequences of folic acid deficiency, such as anemia and developmental disorders, resulting in underutilization of fortified products and supplements. Additionally, variations in government-led nutrition initiatives and healthcare infrastructure pose challenges to widespread education and effective market penetration. This persistent lack of awareness in emerging economies continues to restrict the full realization of folic acid market growth potential.
Expansion into functional foods and beverages
As manufacturers innovate to incorporate folic acid in snacks, drinks, cereals, and dairy products, consumers can supplement their daily intake seamlessly. Furthermore, collaborative government initiatives and mandates for food fortification create ample scope for market participants to diversify portfolios and develop new products tailored to evolving consumer preferences. The ongoing trend of health-oriented diets, focused on convenience and enhanced nutrition, is expected to fuel the market.
Substitute vitamins and nutrients
With consumers' access to a broad range of multivitamins and alternative micronutrient supplements, folic acid faces competition in both awareness campaigns and product formulations. An increasing focus on holistic nutritional intake, rather than targeting single nutrients, could divert attention and expenditures away from folic acid-specific products. Moreover, evolving research on the efficacy of alternative ingredients in addressing similar health conditions may challenge the primacy of folic acid in certain consumer segments.
The Covid-19 pandemic positively influenced the folic acid market by fostering greater awareness of preventative healthcare and immune system support. As consumers became increasingly concerned about maintaining health during the crisis, the demand for supplements, including folic acid, experienced a marked uptick. Additionally, heightened recognition of the importance of micronutrients in combating illness and supporting general well-being led to increased consumption of folic acid-fortified products. This heightened health consciousness is likely to have a lasting impact, reinforcing sustained market growth even beyond the pandemic period.
The pharmaceutical grade segment is expected to be the largest during the forecast period
The pharmaceutical grade segment is expected to account for the largest market share during the forecast period, attributed to the widespread usage of pharmaceutical-grade folic acid in prescription medications and prenatal supplements, where product purity, efficacy, and compliance with regulatory standards are paramount. The segment benefits from a growing prevalence of deficiency disorders, increasing rates of supplementation among women of childbearing age, and recommendations from healthcare professionals. Additionally, the expanding geriatric population and their elevated risk of deficiency-related complications reinforce strong demand for pharmaceutical-grade folic acid solutions.
The online segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the online segment is predicted to witness the highest growth rate, primarily driven by the convenience and accessibility provided by e-commerce platforms, enabling consumers and small-scale buyers to source folic acid supplements with minimal effort. The proliferation of digital health channels and an increasing consumer preference for contactless shopping, accelerated by the pandemic, have further stimulated online sales. Additionally, growing product variety and competitive pricing on online platforms contribute to the robust growth.
During the forecast period, the North America region is expected to hold the largest market share, supported by mature healthcare infrastructure, high awareness regarding the importance of prenatal nutrition, and firmly established governmental fortification mandates. Widespread access to fortified foods and dietary supplements, combined with significant R&D investments by leading pharmaceutical and nutraceutical firms, further underpins North America's leadership. Moreover, regulatory standards ensuring population-wide exposure to folic acid and a large aging demographic continue to support substantial market demand in the region.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. The region's rapid market expansion is propelled by rising disposable income, escalating health awareness, and substantial government initiatives aimed at eradicating nutrient deficiencies. Countries such as China and India are driving this growth with widespread public health programs and free supplementation initiatives targeting women and children. Additionally, an expanding middle class and continual enhancement of healthcare infrastructure are expected to maintain the region's high growth trajectory for folic acid demand.
Key players in the market
Some of the key players in Folic Acid Market include BASF SE, DSM-Firmenich AG, Zydus Lifesciences Limited, Medicamen Biotech Ltd., Jiangxi Tianxin Pharmaceutical Co. Ltd., Emcure Pharmaceuticals Ltd., Balchem Corporation, Xinjiang Wujiaqu Xingnong Cycle Chemical Co. Ltd., Merck KGaA, Lonza Group AG, Parchem Fine & Specialty Chemicals, Xinfa Pharmaceutical Co., Ltd., Nantong Changhai Food Additive Co. Ltd., Hebei Jiheng Group Pharmaceutical Co. Ltd., Gnosis by Lesaffre, Vertellus Holdings LLC, and Shengda Pharmaceutical Co., Ltd.
In May 2025, Emcure Pharmaceuticals has approved the incorporation of a wholly-owned subsidiary named Emcure Generics Private Limited, based in Pune, Maharashtra. The new entity will focus on manufacturing, promoting, selling, and distributing pharmaceutical and related products.
In November 2023, Buhler and dsm-firmenich join forces to advance efforts to combat hidden hunger in Nigeria. In collaboration with Buhler, dsm-firmenich, a leading innovator in health and provider of nutritional solutions, is committed to combatting hidden hunger through the provision of nutritional solutions such as fortified rice. "Nigeria's malnutrition is growing steadily due to factors such as suboptimal diets, economic conditions, and environmental change; it poses a great health risk.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.